EX-10
from 10-Q
10 pages
Employment Agreement This Employment Agreement (“Agreement”), Dated April 19, 2019 and Made Effective the Earlier of May 15, 2019 or the Initial Closing of $1.25 Million of Escrow From the Current $6 Million Finance Offering, (The Employment Start Date”), Is Entered Into by and Between Parallax Health Sciences, Inc. (“The Company”), a Nevada Corporation, (The ‘Employer”), and David Appell, Residing at 3 Paul Place, Blauvelt, New York 10913 (The “Employee”)
12/34/56
EX-10
from 10-K/A
13 pages
Executive Agreement This Executive Agreement (“Agreement”), Effective January 1, 2018, Is Executed on January 20, 2019, by and Between Parallax Health Sciences, Inc., a Nevada Corporation, (The ‘Company”), and Mj Management Services, Inc., a Delaware Corporation, 1702 Delaware Avenue, Santa Monica, Ca 90404 (“Mj Management”), for Services Provided by Calli R. Bucci (The “Executive”), Hereinafter, Collectively, the Parties
12/34/56
EX-10
from 10-K/A
14 pages
Employment Agreement This Employment Agreement (“Agreement”), Dated November 30, 2017, Made Effective August 1, 2017, Is Entered Into by and Between Parallax Health Sciences, Inc. (“The Company”), a Nevada Corporation, (The ‘Employer”), and Nathaniel T. Bradley, 4200 S. Saguaro Path Court, Tucson, Az 85730 (The “Employee”)
12/34/56
EX-10
from 10-K/A
21 pages
Securities Purchase Agreement This Securities Purchase Agreement (This “Agreement”), Dated as of February 27, 2019, Is Entered Into by and Between Parallax Health Sciences, Inc., a Nevada Corporation (The “Company”), and Ema Financial, LLC, a Delaware Limited Liability Company (The “Purchaser”). Whereas, Subject to the Terms and Conditions Set Forth in This Agreement and Pursuant to Section 4(a)(2) of the Securities Act of 1933, as Amended (The “Securities Act” or “1933 Act”),
12/34/56
EX-10
from 10-K/A
48 pages
Exchange Agreement This Exchange Agreement (The “Agreement”) Is Made as of the 31st Day of December and Effective November 14, 2018, by and Between, Parallax Health Sciences, Inc., a Nevada Corporation, (The “Company”) and Cavalry Fund I LP, a Delaware Limited Partnership (The “Investor”). Whereas, the Investor Has Previously Acquired Various Securities From the Company in the Form of Convertible Notes With Various Dates of Issuance as Set Forth on Schedule I (The “Notes”). Whereas, the Company Has Authorized a New Series of Convertible Debenture Due
12/34/56
EX-10
from 8-K
20 pages
Securities Purchase Agreement This Securities Purchase Agreement (This “Agreement”), Dated as of April 8, 2019, Is Entered Into by and Between Parallax Health Sciences, Inc., a Nevada Corporation (The “Company”), and Ema Financial, LLC, a Delaware Limited Liability Company (The “Purchaser”). Whereas, Subject to the Terms and Conditions Set Forth in This Agreement and Pursuant to Section 4(a)(2) of the Securities Act of 1933, as Amended (The “Securities Act” or “1933 Act”),
12/34/56
EX-10
from 8-K
17 pages
Or Prior to 5 Pm New York City Time on March 18, 2024 (The “Termination Date”) but Not Thereafter, to Subscribe for and Purchase From Parallax Health Sciences, Inc., a Nevada Corporation (The “Company”), Up to 1,300,000 Shares (As Subject to Adjustment Hereunder, the “Warrant Shares”) of Common Stock. the Purchase Price of One Share of Common Stock Under This Warrant Shall Be Equal to the Exercise Price, as Defined in Section 1.00(b). Section 1.00 Exercise
12/34/56
